NCT02568878

Creatine for Depressed Male and Female Methamphetamine Users

An Open-Label Pilot Study of Creatine for Depressed Male and Female Methamphetamine Users

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 29 (estimated)
• Sponsor: Montana State University · Academic / Other
• Sex: All
• Age: 18 Years – 59 Years
• Healthy volunteers: Not accepted

Summary

* Assess the antidepressant/anxiolytic effect of creatine in male and female methamphetamine users * Assess creatine's effect on methamphetamine use * Assess the safety of creatine in male methamphetamine users with depression

Conditions

• Depression
• Anxiety
• Methamphetamine Dependence

Interventions

Type	Name	Description
DRUG	Creatine monohydrate

Timeline

• Start date: 2015-11-01
• Primary completion: 2016-10-01
• Completion: 2017-05-01
• First posted: 2015-10-06
• Last updated: 2015-12-11

Locations

1 site across 1 country: United States